Matches in Nanopublications for { ?s ?p "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP915245.RA-fxGvgC63ee3HczMW5L9sf3rSyXjFTLLMUXdy6lAWx0130_assertion description "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915245.RA-fxGvgC63ee3HczMW5L9sf3rSyXjFTLLMUXdy6lAWx0130_provenance.
- assertion description "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP272182.RAkEQ3GjNfXJG2tfzb7BBmZHG_A0qiV2ieLMhKYRugcSI130_assertion description "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272182.RAkEQ3GjNfXJG2tfzb7BBmZHG_A0qiV2ieLMhKYRugcSI130_provenance.
- NP800263.RAcTlBOsTb5lpTfEJrax_Jt3VI-qTTPYM_NT5qHVv6-WI130_assertion description "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800263.RAcTlBOsTb5lpTfEJrax_Jt3VI-qTTPYM_NT5qHVv6-WI130_provenance.
- NP485775.RAmgOkydDlaGeofrRXXeI8hySG2qRiQUOUC0I5OrBg-2Q130_assertion description "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485775.RAmgOkydDlaGeofrRXXeI8hySG2qRiQUOUC0I5OrBg-2Q130_provenance.
- NP800266.RAjp0sOoF5Az_lWNn0YXuSAOY_x3YK6PWjntccSjCxiCA130_assertion description "[The disparate expression of IGFBP7 in BRAFV600E-positive dysplastic nevi (enhanced in 56% and diminished/absent in 44%) indicates that the behavior of oncogenic BRAF in dysplastic nevi, unlike that in malignant melanoma, does not appear to consistently induce senescence/apoptosis through pathways mediated by IGFBP7.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800266.RAjp0sOoF5Az_lWNn0YXuSAOY_x3YK6PWjntccSjCxiCA130_provenance.